Sign In
Buy NTR
$61.54
-0.710 (-1.14%)
At Close: Jun 23, 2026
Nutrien (NTR) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
11:06am, Wednesday, 31'st Jul 2024
Nutrien (NTR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Nutrien Announces Release Dates for Second Quarter 2024 Results and Conference Call
02:01pm, Tuesday, 16'th Jul 2024
SASKATOON, Saskatchewan--(BUSINESS WIRE)--Nutrien Ltd. (TSX and NYSE: NTR) announced today plans to release second quarter 2024 results after market close on Wednesday, August 7. Nutrien will host a c
These 2 Basic Materials Stocks Could Beat Earnings: Why They Should Be on Your Radar
09:55am, Monday, 24'th Jun 2024
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Nutrien (NTR) Prices $1 Billion of 3-Year & 10-Year Senior Notes
10:05am, Tuesday, 18'th Jun 2024
The senior notes will be unsecured and will rank on an equal footing with Nutrien's (NTR) current senior unsecured debt.
3 Cash Cows to Milk for Massive Yields for Decades to Come
08:30am, Tuesday, 18'th Jun 2024
Inflation is cooling, but the Federal Reserve's wait-and-see approach could postpone any swift interest rate cuts. Hence, it's probably the perfect time to anchor your portfolio with resilient cash co
Nutrien Prices Offering of an Aggregate of US$1.0 Billion of 3-Year and 10-Year Senior Notes
06:30pm, Monday, 17'th Jun 2024
SASKATOON, Saskatchewan--(BUSINESS WIRE)--Nutrien Ltd. (TSX and NYSE: NTR) today announced the pricing of US$400 million aggregate principal amount of 5.200 percent senior notes due June 21, 2027 and
Nutrien to Highlight Strategic Priorities and 2026 Targets at Investor Day
08:30am, Wednesday, 12'th Jun 2024
SASKATOON, Saskatchewan--(BUSINESS WIRE)--Nutrien Ltd. (TSX and NYSE: NTR) today is hosting an Investor Day at the New York Stock Exchange beginning at 10:00 a.m. EDT. At the event, management will de
Zacks Industry Outlook Nutrien, ICL and Intrepid Potash
05:50am, Wednesday, 12'th Jun 2024
Nutrien, ICL and Intrepid Potash have been highlighted in this Industry Outlook article.
3 Top Fertilizer Stocks to Watch From a Promising Industry
09:30am, Tuesday, 11'th Jun 2024
Favorable demand in major markets for crop nutrients, backed by the strength in global agriculture markets, should enable the Zacks Fertilizers industry to thrive. NTR, ICL and IPI should benefit from
Here's Why You Should Retain Nutrien (NTR) in Your Portfolio
09:11am, Thursday, 06'th Jun 2024
While Nutrien (NTR) is exposed to pricing pressure, it benefits from solid demand for fertilizers, backed by the strength in global agriculture markets.
Nutrien (NTR) Shares Pop 15% in 3 Months: What's Driving It?
07:40am, Monday, 03'rd Jun 2024
Nutrien (NTR) gains on strong demand for crop nutrients on the strength in global agriculture markets and its cost and operational efficiency initiatives.
Nutrien (NTR) Gains on Demand Strength Amid Pricing Headwinds
09:10am, Tuesday, 28'th May 2024
While Nutrien (NTR) is exposed to pricing pressure, it benefits from solid demand for fertilizers, backed by the strength in global agriculture markets.
3 Growth Stocks the New ‘GPT-4o' AI Bot Says Will Make You Rich
12:55pm, Monday, 27'th May 2024
OpenAI has recently released its GPT-4o AI bot, touted as a more advanced version of its previous language models. This new bot is more focused on voice inputs and usefulness in day-to-day living t
The Commodity Kings: 3 Stocks to Dig Into Now
09:00am, Saturday, 25'th May 2024
Investors have been navigating a complex financial landscape marked by persistent inflation and geopolitical uncertainties. Amid this backdrop, commodity stocks to buy remain a focal point.
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Altimmune, Inc. (ALT) Investors
12:09pm, Monday, 13'th May 2024
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Altimmune, Inc. (ALT) Investors.
